



IMS to Present at UBS Global Healthcare Services Conference on February 11 at 9:30 a.m. ET
NORWALK, Conn.--([ BUSINESS WIRE ])--IMS Health (NYSE: RX), the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that Leslye G. Katz, senior vice president and chief financial officer, will speak to investors and analysts attending the 2009 UBS Global Healthcare Services Conference, to be held at The Waldorf Astoria in New York, NY on February 9-11, 2009.
To listen to a live audio Webcast of the IMS presentation on Wednesday, February 11, 2009 at 9:30 a.m. ET, go to [ http://cc.talkpoint.com/ubsx001/020909a_cy/?entity=27_807IU7W ]. A replay of the presentation will be available until February 18, 2009.
About IMS
Operating in more than 100 countries, IMS Health is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients' day-to-day operations, including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide. Additional information is available at [ http://www.imshealth.com ].